• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 Angioscan 观察动脉高血压、冠心病和糖尿病患者的血管内皮功能障碍

Endothelial Dysfunction under the Scope of Arterial Hypertension, Coronary Heart Disease, and Diabetes Mellitus using the Angioscan.

机构信息

World-Class Research Center, Digital Biodesign and Personalized Healthcare, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991, Moscow, Russia.

出版信息

Cardiovasc Hematol Agents Med Chem. 2024;22(2):181-186. doi: 10.2174/0118715257246589231018053646.

DOI:10.2174/0118715257246589231018053646
PMID:37921186
Abstract

BACKGROUND

Cardiovascular disease and diabetes mellitus are among the leading causes of mortality.

OBJECTIVES

Our study evaluated endothelial function in patients with arterial hypertension, coronary heart disease, and diabetes mellitus.

AIMS

This study aimed to assess the degree of endothelial dysfunction in individuals with cardiovascular risk factors older than 55 years of age.

MATERIALS AND METHODS

A total of 112 patients were subdivided into three groups according to the existing disease; the first group consisted of 50 patients diagnosed with arterial hypertension (AH), the second group consisted of 30 patients with ischemic heart disease (IHD), and the third group included 20 patients with type 2 diabetes mellitus (DM). The control group included 12 practically healthy volunteers, comparable in age and sex. Exclusion criteria were age under 55 years, severe concomitant diseases in the acute phase or acute infectious diseases, and oncopathology. Considered factors of cardiovascular risk include dyslipidemia, elevated fasting blood glucose, hypertension, obesity, cigarette smoking, and heredity for CVD. Moreover, tests were conducted with the help of the device 'AngioScan-01' (LLC "AngioScan Electronics"). Endothelium-dependent vasodilation (EDV), the index of stiffness of the vascular wall (SI), and the atherogenic index (log ( )) were evaluated. The analysis of the data obtained was carried out using the IBM SPSS Statistic program.

RESULTS

In the control group, the atherogenic index was in the range of 3.34 (the normal is up to 3.5). The highest atherogenic index, 4.01, was observed in the DM group (differences with the control group are statistically significant). In the AH and IHD groups, the atherogenic index was 3.57 and 3.65, respectively. In the control group, the level of glycemia was 4.45 mmol/l. The highest level of fasting glucose was reported in the DM group, , 6.7 mmol/l (differences with the control group were statistically significant). In the first and second groups, the fasting glucose level was 5.07 mmol/l and 5.08 mmol/l, respectively. In the control group, the mean EDV score was 2,056 ± 0.757 mm, and the lowest EDV in the DM group was 1.365 ± 0.413, but in the AH and IHD groups, it was also significantly reduced by 1.404 ± 0.440 and 1.377 ± 0.390, respectively. The stiffness index in the control group was 6.725 ± 0.776 m/s. In the DM group, this parameter was 8.258 ± 0.656 m/s; in the AH and IHD groups, it was 7.398 ± 1.330 m/s and 7.486 ± 0.816 m/s, respectively.

CONCLUSION

In conclusion, the study of endothelial function using non-invasive angioscan reflects the influence of risk factors on the vascular wall. The most severe endothelial dysfunction is expressed in patients with diabetes. The results of endothelium-dependent vasodilation and the vascular wall stiffness index (SI) correspond to the scale of evaluation of the 10-year CVD mortality risk (SCORE). These results indicate a deterioration in the vascular ability to vasodilate in patients in response to mechanical deformation of the endothelium and the effect of NO on smooth muscle vascular cells.

摘要

背景

心血管疾病和糖尿病是主要的死亡原因之一。

目的

我们的研究评估了动脉高血压、冠心病和糖尿病患者的内皮功能。

目的

本研究旨在评估年龄大于 55 岁的心血管危险因素患者的内皮功能障碍程度。

材料和方法

根据现有疾病将 112 名患者分为三组;第一组 50 名患者诊断为动脉高血压(AH),第二组 30 名患者患有缺血性心脏病(IHD),第三组包括 20 名 2 型糖尿病(DM)患者。对照组包括 12 名实际健康志愿者,年龄和性别相当。排除标准为年龄小于 55 岁、急性阶段的严重合并症或急性传染病以及肿瘤病理学。考虑的心血管危险因素包括血脂异常、空腹血糖升高、高血压、肥胖、吸烟和 CVD 遗传。此外,使用设备'AngioScan-01'(LLC“AngioScan Electronics”)进行测试。评估了内皮依赖性血管舒张(EDV)、血管壁僵硬指数(SI)和动脉粥样硬化指数(log())。使用 IBM SPSS Statistic 程序对获得的数据进行分析。

结果

在对照组中,动脉粥样硬化指数在 3.34 范围内(正常范围为 3.5 以下)。在 DM 组中观察到最高的动脉粥样硬化指数 4.01(与对照组差异具有统计学意义)。在 AH 和 IHD 组中,动脉粥样硬化指数分别为 3.57 和 3.65。在对照组中,血糖水平为 4.45mmol/l。DM 组报告的空腹血糖水平最高,为 6.7mmol/l(与对照组差异具有统计学意义)。在第一和第二组中,空腹血糖水平分别为 5.07mmol/l 和 5.08mmol/l。在对照组中,平均 EDV 评分为 2.056±0.757mm,DM 组的 EDV 最低为 1.365±0.413,但在 AH 和 IHD 组中,EDV 也分别显著降低至 1.404±0.440 和 1.377±0.390。对照组的刚度指数为 6.725±0.776m/s。在 DM 组中,该参数为 8.258±0.656m/s;在 AH 和 IHD 组中,分别为 7.398±1.330m/s 和 7.486±0.816m/s。

结论

总之,使用非侵入性的血管扫描研究内皮功能反映了危险因素对血管壁的影响。在糖尿病患者中,内皮功能障碍最严重。内皮依赖性血管舒张和血管壁僵硬指数(SI)的结果与心血管疾病 10 年死亡率风险(SCORE)的评估量表相对应。这些结果表明,在患者中,血管对机械变形的内皮和一氧化氮对平滑肌血管细胞的影响的舒张能力恶化。

相似文献

1
Endothelial Dysfunction under the Scope of Arterial Hypertension, Coronary Heart Disease, and Diabetes Mellitus using the Angioscan.利用 Angioscan 观察动脉高血压、冠心病和糖尿病患者的血管内皮功能障碍
Cardiovasc Hematol Agents Med Chem. 2024;22(2):181-186. doi: 10.2174/0118715257246589231018053646.
2
[Effect of metabolic factors on the vasorelaxation endothelial function in patients with type II diabetes and arterial hypertension].[代谢因素对2型糖尿病合并动脉高血压患者血管舒张内皮功能的影响]
Klin Med (Mosk). 2005;83(10):25-30.
3
Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.雌激素对绝经后糖尿病女性内皮功能障碍的影响。
Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S81-92. doi: 10.1016/s0168-8227(01)00339-4.
4
Interaction of hypertension and diabetes on impairment of endothelial function.高血压与糖尿病对内皮功能损害的相互作用。
Chin Med J (Engl). 2001 Jun;114(6):563-7.
5
Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature.2型糖尿病与动脉高血压并存对人前臂血管系统阻力动脉内皮功能障碍的叠加效应。
Angiology. 2000 Jul;51(7):545-54. doi: 10.1177/000331970005100703.
6
Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell.以内皮功能和内皮祖细胞为特征的糖尿病和动脉疾病中的冠心病风险等同性。
J Diabetes Complications. 2014 Mar-Apr;28(2):214-8. doi: 10.1016/j.jdiacomp.2013.09.009. Epub 2013 Oct 4.
7
[Vascular dysfunction in young patients with impaired glucose tolerance: insights from pulse wave velocity and endothelial function measurements].糖耐量受损年轻患者的血管功能障碍:脉搏波速度和内皮功能测量的见解
Przegl Lek. 2002;59(9):765-9.
8
[Combined antihypertensive treatment of patients with hypertension and type 2 diabetes mellitus].高血压合并2型糖尿病患者的联合降压治疗
Ter Arkh. 2009;81(2):75-9.
9
Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure.运动训练计划对重度慢性心力衰竭的糖尿病和非糖尿病患者内皮功能障碍的影响。
Clin Res Cardiol. 2006 Jan;95 Suppl 1:i117-24. doi: 10.1007/s00392-006-1106-z.
10
Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer.外周内皮功能评估可预测实体肿瘤癌症的未来风险。
Eur J Prev Cardiol. 2020 Apr;27(6):608-618. doi: 10.1177/2047487319884246. Epub 2019 Oct 31.

引用本文的文献

1
Updates in breathomics behavior in ischemic heart disease and heart failure, mass-spectrometry.缺血性心脏病和心力衰竭中呼吸代谢组学行为的最新进展,质谱分析
World J Cardiol. 2025 Feb 26;17(2):102851. doi: 10.4330/wjc.v17.i2.102851.
2
Volatilome is Inflammasome- and Lipidome-dependent in Ischemic Heart Disease.挥发性代谢组学依赖于缺血性心脏病中的炎症小体和脂质组学。
Curr Cardiol Rev. 2024;20(6):e190724232038. doi: 10.2174/011573403X302934240715113647.
3
Volatilome: A Novel Tool for Risk Scoring in Ischemic Heart Disease.挥发物组学:缺血性心脏病风险评分的新工具。

本文引用的文献

1
Tree of life: endothelial cell in norm and disease, the good guy is a partner in crime!生命之树:正常与疾病状态下的内皮细胞,好人竟是共犯!
Anat Cell Biol. 2023 Jun 30;56(2):166-178. doi: 10.5115/acb.22.190. Epub 2023 Mar 7.
2
Endothelial cell autophagy in the context of disease development.疾病发展背景下的内皮细胞自噬
Anat Cell Biol. 2023 Mar 31;56(1):16-24. doi: 10.5115/acb.22.098. Epub 2022 Oct 21.
3
Autophagy in Cancer Cell Transformation: A Potential Novel Therapeutic Strategy.自噬在肿瘤细胞转化中的作用:一种潜在的新型治疗策略。
Curr Cardiol Rev. 2024;20(6):e080724231719. doi: 10.2174/011573403X304090240705063536.
4
Breathomics Detect the Cardiovascular Disease: Delusion or Dilution of the Metabolomic Signature.呼吸组学检测心血管疾病:代谢组学特征的错觉还是稀释。
Curr Cardiol Rev. 2024;20(4):e020224226647. doi: 10.2174/011573403X283768240124065853.
Curr Cancer Drug Targets. 2022;22(9):749-756. doi: 10.2174/1568009622666220428102741.
4
Flow goes forward and cells step backward: endothelial migration.血流向前,细胞却向后移动:血管内皮细胞迁移。
Exp Mol Med. 2022 Jun;54(6):711-719. doi: 10.1038/s12276-022-00785-1. Epub 2022 Jun 14.
5
The Metabolic Syndrome Puzzles; Possible Pathogenesis and Management.代谢综合征之谜;可能的发病机制和治疗方法。
Curr Diabetes Rev. 2023;19(4):e290422204258. doi: 10.2174/1573399818666220429100411.
6
Transcription Factors - the Essence of Heart Regeneration: A Potential Novel Therapeutic Strategy.转录因子——心脏再生的本质:一种潜在的新型治疗策略。
Curr Mol Med. 2023;23(3):232-238. doi: 10.2174/1566524022666220216123650.
7
Lipid Behavior in Metabolic Syndrome Pathophysiology.代谢综合征病理生理学中的脂质行为
Curr Diabetes Rev. 2022;18(6):e150921196497. doi: 10.2174/1573399817666210915101321.
8
Guidelines for the measurement of vascular function and structure in isolated arteries and veins.血管功能和结构的离体动脉和静脉测量指南。
Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H77-H111. doi: 10.1152/ajpheart.01021.2020. Epub 2021 May 14.
9
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
10
[Role of markers of inflammation and endothelial dysfunction in the prognosis of the development of cardiovascular complications in patients with coronary artery disease and metabolic syndrome after coronary stenting].[炎症和内皮功能障碍标志物在冠心病合并代谢综合征患者冠状动脉支架置入术后心血管并发症发生预后中的作用]
Kardiologiia. 2020 Sep 17;60(8):98-105. doi: 10.18087/cardio.2020.8.n966.